Rumor Alert: This Big Pharma Have Hired Bankers to Fend Off Deal-Hungry Suitors
Astellas (ALPMY) Takes a $387 Million+ Loss as It Shuts Down SoCal's Agensys
Alexion (ALXN) Redefines R&D Strategy, Discontinues Programs and Kills Deals With Moderna, Blueprint (BPMC) and Arbutus Biopharma (ABUS)
AstraZeneca PLC (AZN) Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co. (MRK)
Bavarian Nordic (BAVA.CO) Rockets on Expanded $846 Million HIV-Hepatitis B Deal With Johnson & Johnson (JNJ)
Not-Yet Sold Tesaro (TSRO) Bags $340 Million Cancer Deal With Pharma Giant Takeda (TKPYY)
Amgen (AMGN) Falls After Earnings Update Reveals Embarassingly 'Bare' Pipeline
Why Gilead (GILD) Should Consider Breaking the Company Up Into Two
AstraZeneca PLC (AZN) Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints
This Pharma Jumped 60% in One Month
Bristol-Myers Squibb (BMY) Slaps Lawsuit on Biotech Pioneer Genentech (RHHBY) Over Cancer Immunotherapy Patents
McKesson (MCK) Executive Pay Package Plan Rejected by Shareholders
CRISPR (CRSP) to Lose Its CFO in September, Hunt for Successor Begins
2 Pharma Giants Pfizer (PFE) Could Make a Megadeal on Soon
GlaxoSmithKline (GSK) CEO Kills 30+ Pre-Clinical and Clinical Programs
FDA Head Postpones Layoff Notices of Thousands of Employees
Death Count Rises for Patients on Dynavax (DVAX)'s Hep B Vaccine But Overall Rate Was Low, Says the FDA
Heads Up Startups: Silicon Valley VC Firm—With an Appetite for Biotech—Nabs Record $800 Million Fund
See All News >
Brain Cells Found To Control Aging, Albert Einstein College of Medicine Study Reveals
Drinking Alcohol After Studying Can Improve Memory, Scientific Reports Reveals
Diabetes Crisis Continues To Rage, But Biopharma's Response Is Tepid
Alere (ALR) Employees to Transition to Quidel (QDEL), Siemens (SI) After Abbott (ABT) Divests Three Businesses
iCyborg: Apple (AAPL) Just Announced The First Mass Market Cyborg Enhancement
San Diego's Sotera Wireless Materializes From Bankruptcy With $32 Million
Researchers Engineer 3-D Hydrogels For Tissue-Specific Cartilage Repair, Stanford Reveals
Robot-Driven Device Improves Crouch Gait In Children With Cerebral Palsy, Columbia University School of Engineering and Applied Science Study Reveals
Color-Shifting Electronic Skin Could Have Wearable Tech And Prosthetic Uses, Tsinghua University Study
Pennsylvania Judge Reverses Johnson & Johnson (JNJ)'s Pelvic Mesh Win
Biogen (BIIB) Is Hunting For Neuroscience Deals Of All Sizes
Science Says This Is The One Way Money Can Buy Happiness, University of British Columbia Study
The Startling History Behind Merck & Co. (MRK)'s New Cancer Blockbuster
Neurotic People May Live Longer, University of Edinburgh Study Finds
The 1 Biotech Stock You Can Safely Own For The Next 13 Years
Distinctive Corporate Culture In Biotech: Walk The Talk
Researchers Develop DNA Sunscreen That Gets Better The Longer You Wear It, Binghamton University Reveals
Color-Shifting Electronic Skin Could Have Wearable Tech And Prosthetic Uses, Tsinghua University Study
See All News >
Biogen (BIIB) May Cut Jobs, Shutter Facilities to Streamline Ops and Free Up $400 Million for R&D
Eli Lilly (LLY) Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs
Google (GOOG) Quietly Invests in This Cancer-Testing Startup, Builds Lab on Verily (GOOGL) Campus to Sweeten Deal
2 Tiny Cancer Biotechs That Could Gain Steam by Year-End
Boehringer Ingelheim Aims for 300 New Bay Area Jobs With $217 Million Expansion
Merck & Co. (MRK) Dealt Another Setback as Its Ace Keytruda Comes Up Short in Head and Neck Cancer Study
Blood Clot Fears Delay Eli Lilly (LLY), Incyte (INCY)'s Potential Rheumatoid Arthritis Blockbuster, Stocks Fall
Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech
Teva (TEVA) to Slash Up to 350 Employees in Reorg
5 Biotechs With $45 Billion Worth of Not-Yet Approved Drugs in the Pipeline
Massachusetts’ Histogenics Looks to NeoCart for Replacing Knee Cartilage Loss
The Problem With Saying John McCain Can 'Fight' His Cancer
Bay Area's Nektar (NKTR) Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly (LLY)
Texas Officials Lure Life Sciences Companies Like Merck & Co. (MRK), Which is Expected to Employ 600
Brace Yourself: GlaxoSmithKline (GSK)'s New CEO Gets Ready to Overhaul the Drug Pipeline
AbbVie (ABBV), Eli Lilly (LLY) and Johnson & Johnson (JNJ) Get in on Rodeo Therapeutics' Series A Funding Round
3 Key Things Every CAR-T Investor Should Watch
VenatoRx Pharma Banks $42 Million to Advance Antibiotics Pipeline
See All News >